Inevitable Decline? Inside the Founder's Studio on Neuroscience Insights

Aging includes cognitive decline in one form or another for everyone. While major studies continue to track long-term assessment, companies are identifying new approaches to brain health that may change everything, from earlier identification of decline to better and more targeted treatment.

In this episode of Inside the Founder's Studio, CTC talks to Seth Rodgers, founder of NeuroSave, and Caitlyn Krebs, COO of Neurotrack, about their companies' unique solutions to the complex issues around brain health.

Catch a panel discussion with BioCalifornia featuring these companies on September 21st in Palo Alto. For more information, CLICK HERE.

For more of CTC's podcasts, please visit our PODCAST ARCHIVE HERE.

Listen to this podcast here: